APODDC
@apoddc
Followers
86
Following
192
Media
19
Statuses
111
We’ll be hosting Clinical Trial Design webinars in 2023! Follow us to be kept up to date. 📊🧑🏻💻
Joined June 2022
RT @herbloong: 📢 #Happy to share w/ #LCSM community! After 3+ years of work, we are pleased to share our #cost_effectiveness modelling for….
0
9
0
RT @ESMO_Open: Safety of tarlatamab with 6-8h outpatient vs 48-h inpatient monitoring during C1: DeLLphi-300 ph1 substudy in @ESMO_Open. Ou….
0
12
0
RT @herbloong: Wonderful crew of @myESMO #ESMORarecancer25 #YOCasesDiscussion session! Definitely not-so-young oncologists including #mysel….
0
5
0
RT @lillian_siu: It's pleasure coauthoring this @Cancer_Cell commentary with 2 talented drug development fellows #gregoire marret and #merc….
0
31
0
RT @HHorinouchi: 🔥 @JCO_ASCO 🆙.✅LIBRETTO-001 final: Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer.🎯mOS 47.6 (pretreated p….
0
18
0
RT @stephanieplsaw: Delighted to share our review paper on ADCs in NSCLC with AGA is out! Very timely given the anticipated data readouts t….
0
20
0
RT @bvantine1: It's ok at #CTOS2024 to drag me to your poster to pitch your science for Clinical Cancer Research, it the most inspiring thi….
0
4
0
RT @herbloong: Thanks @drkiwicj @drkiwikate @anmwongNZ @cameroncologist #DaisyMak (who needs to get on Twitter! 😆) & all my other 🇳🇿 #oncol….
0
3
0
RT @anmwongNZ: Thank you superstar @herbloong for being a keynote speaker @NzsOncology . Timely discussions on accessibility/ cost savings….
0
2
0
RT @Winette_vdGraaf: Thank you @jeanyvesblay for your excellent talk at the @cddf_eu - @EORTC workshop #RareCancers. You last slides summa….
0
3
0
RT @herbloong: Thanks @drdgoldstein for coming all the way from 🇮🇱 to 🇭🇰 to share insights and experiences in #pharmacoeconomics. Organised….
0
5
0
📢Announcement: Join us at our 1st #APODDCForum2024 where we discuss about the Regulatory Harmonisation for Oncology Clinical Trials & Therapeutics Registration in the APAC Region📷 Sign up now via 📧 More details on our LinkedIn Page!
0
0
0
RT @herbloong: 📢 T-28 days to our 6th @CUHKMedicine #CUHKSarcoma Masterclass in #hongkong 🇭🇰! We are looking forward to welcoming #internat….
0
3
0
RT @APassaroMD: Truly honored to have been invited to speak on EGFR-mut NSCLC at the National Cancer Center in Singapore by Daniel Tan and….
0
11
0
RT @herbloong: Congrats @jeanyvesblay & colleagues of #FrenchSarcomaGroup for completing study of #6vs3years of #adjuvant #imatinib 💊i n pt….
0
7
0
RT @myESMO: #ESMOVirtualPlenary: And straight after the first abstract session tomorrow (9/5), remain connected to discover more promising….
0
8
0
RT @RashidLui: Prof Jacky Lam sharing at the @CUHKMedicine Department of Clinical Oncology Academic Meeting on liquid biopsy for early canc….
0
2
0
RT @herbloong: Kicked off @ASCO #AsiaPacific #RegionalCouncil meeting in #Kuching #Sarawak 🇲🇾 w/ dedicated council members representing our….
0
2
0